{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T06:32:53Z","timestamp":1794724373680,"version":"4.9.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.eururo.2019.09.029","type":"journal-article","created":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T00:38:05Z","timestamp":1572914285000},"page":"101-109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":194,"title":["Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non\u2013muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection"],"prefix":"10.1016","volume":"77","author":[{"given":"Francesco","family":"Del Giudice","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Barchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ettore","family":"De Berardinis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Pecoraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Salvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Sciarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1407-0424","authenticated-orcid":false,"given":"Costantino","family":"Leonardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Gallucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Catalano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.F.","family":"Catto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Panebianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2019.09.029_bib0005","series-title":"GLOBOCAN 2012 v1.0: estimated cancer incidence, mortality and prevalence worldwide in 2012, 2013","author":"Ferlay","year":"2015"},{"key":"10.1016\/j.eururo.2019.09.029_bib0010","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00428-015-1739-2","article-title":"Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years old","volume":"466","author":"Comp\u00e9rat","year":"2015","journal-title":"Virchows Arch"},{"key":"10.1016\/j.eururo.2019.09.029_bib0015","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.eururo.2011.05.045","article-title":"Long-term cancer-specific survival in patients with high-risk, non-muscle-invasive bladder cancer and tumour progression: a systematic review","volume":"60","author":"van den Bosch","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2019.09.029_bib0020","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.eururo.2012.07.026","article-title":"Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis","volume":"64","author":"Fajkovic","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2019.09.029_bib0025","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1442-2042.2012.03148.x","article-title":"Stage-specific impact of extended versus standard pelvic lymph node dissection in radical cystectomy","volume":"20","author":"Simone","year":"2013","journal-title":"Int J Urol"},{"issue":"9 Pt B","key":"10.1016\/j.eururo.2019.09.029_bib0030","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/j.1464-410X.2008.07966.x","article-title":"Quality control in transurethral resection of bladder tumours","volume":"102","author":"Herr","year":"2008","journal-title":"BJU Int"},{"issue":"2 Pt 2","key":"10.1016\/j.eururo.2019.09.029_bib0035","article-title":"The value of extended transurethral resection of bladder tumour (TURBT) in the treatment of bladder cancer","volume":"110","author":"Richterstetter","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2019.09.029_bib0040","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0302-2838(02)00068-4","article-title":"Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies","volume":"41","author":"Brausi","year":"2002","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2019.09.029_bib0045","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.eururo.2009.05.047","article-title":"Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience","volume":"57","author":"Mariappan","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2019.09.029_bib0050","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.eururo.2010.03.007","article-title":"Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomised clinical trial","volume":"58","author":"Divrik","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2019.09.029_bib0055","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s00345-013-1205-1","article-title":"Clinical significance of definite muscle layer in TUR specimen for evaluating progression rate in T1G3 bladder cancer: multicenter retrospective study by the Sapporo Medical University Urologic Oncology Consortium (SUOC)","volume":"32","author":"Shindo","year":"2014","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2019.09.029_bib0060","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","article-title":"EAU guidelines on non-muscle invasive urothelial carcinoma of the bladder: update 2016","volume":"71","author":"Babjuk","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2019.09.029_bib0065","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.eururo.2011.09.019","article-title":"Potential and limitations of diffusion-weighted magnetic resonance imaging in kidney, prostate, and bladder cancer including pelvic lymph node staging: a critical analysis of the literature","volume":"61","author":"Giannarini","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2019.09.029_bib0070","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1007\/s00330-017-4758-3","article-title":"An evaluation of morphological and functional multi-parametric MRI sequences in classifying non-muscle and muscle invasive bladder cancer","volume":"27","author":"Panebianco","year":"2017","journal-title":"Eur Radiol"},{"key":"10.1016\/j.eururo.2019.09.029_bib0075","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.eururo.2018.04.029","article-title":"Multiparametric magnetic resonance imaging for bladder cancer: development of VI-RADS (Vesical Imaging-Reporting and Data System)","volume":"74","author":"Panebianco","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2019.09.029_bib0080","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.eururo.2019.03.046","article-title":"Should we perform multiparametric magnetic resonance imaging of the bladder before transurethral resection of bladder? Time to reconsider the rules","volume":"76","author":"Panebianco","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2019.09.029_bib0085","doi-asserted-by":"crossref","first-page":"5498","DOI":"10.1007\/s00330-019-06117-8","article-title":"Multiparametric MRI of the bladder: inter-observer agreement and accuracy with the Vesical Imaging-Reporting and Data System (VI-RADS) at a single reference center","volume":"29","author":"Barchetti","year":"2019","journal-title":"Eur Radiol"},{"key":"10.1016\/j.eururo.2019.09.029_bib0090","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.eururo.2019.03.012","article-title":"Diagnostic accuracy and interobserver agreement for the Vesical Imaging-Reporting and Data System for muscle-invasive bladder cancer: a multireader validation study","volume":"76","author":"Ueno","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2019.09.029_bib0095","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1148\/radiol.2019182506","article-title":"Multiparametric MRI for bladder cancer: validation of VI-RADS for the detection of detrusor muscle invasion","volume":"291","author":"Wang","year":"2019","journal-title":"Radiology"},{"key":"10.1016\/j.eururo.2019.09.029_bib0100","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.eururo.2018.02.014","article-title":"Repeat transurethral resection in non-muscle-invasive bladder cancer: a systematic review","volume":"73","author":"Cumberbatch","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2019.09.029_bib0105","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.euf.2016.12.011","article-title":"Role of restaging transurethral resection for T1 non-muscle invasive bladder cancer: a systematic review and meta-analysis","volume":"4","author":"Naselli","year":"2018","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.eururo.2019.09.029_bib0110","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.eursup.2009.06.003","article-title":"Transurethral resection of non-muscle-invasive bladder cancer","volume":"8","author":"Babjuk","year":"2009","journal-title":"Eur Urol Suppl"},{"key":"10.1016\/j.eururo.2019.09.029_bib0115","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.eururo.2014.01.006","article-title":"The economics of bladder cancer: costs and considerations of caring for this disease","volume":"66","author":"Svatek","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2019.09.029_bib0120","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.juro.2014.05.100","article-title":"Comparison of perioperative outcomes including severe bladder injury between monopolar and bipolar transurethral resection of bladder tumors: a population-based comparison","volume":"192","author":"Sugihara","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2019.09.029_bib0125","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.acuro.2014.01.001","article-title":"Second transurethral resection and prognosis of high-grade non-muscle invasive bladder cancer in patients not receiving bacillus Calmette-Gu\u00e9rin","volume":"38","author":"Angulo","year":"2014","journal-title":"Acta Urol Esp"},{"key":"10.1016\/j.eururo.2019.09.029_bib0130","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.juro.2013.11.005","article-title":"Members of the Urothelial Cancer Group of the Nordic Association of Urology. 5-Year outcome of a randomized prospective study comparing bacillus Calmette-Gu\u00e9rin with epirubicin and interferon-\u03b12b in patients with T1 bladder cancer","volume":"191","author":"Hemdan","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2019.09.029_bib0135","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/bju.13354","article-title":"The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade\/grade 3 bladder cancer treated with bacille Calmette-Gu\u00e9rin","volume":"118","author":"Gontero","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2019.09.029_bib0140","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0022-5347(05)66442-7","article-title":"Fluorescence endoscopy with 5-aminolevulinic acid reduces early recurrence rate in superficial bladder cancer","volume":"165","author":"Riedl","year":"2001","journal-title":"J Urol"},{"issue":"8 Pt 2","key":"10.1016\/j.eururo.2019.09.029_bib0145","doi-asserted-by":"crossref","first-page":"E297","DOI":"10.1111\/j.1464-410X.2011.10090.x","article-title":"Fluorescence-guided transurethral resection of bladder tumours reduces bladder tumour recurrence due to less residual tumour tissue in Ta\/T1 patients: a randomized two-centre study","volume":"108","author":"Hermann","year":"2011","journal-title":"BJU Int"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283819307572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283819307572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T13:06:07Z","timestamp":1759583167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283819307572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0302283819307572"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2019.09.029","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non\u2013muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2019.09.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}